Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B

Table 1

Clinical parameters of participants in validation.

Parameters	CHB with LGDHS	CHB with LKYDS	Ctrl
Individuals (𝑛)	32	21	21
Male	26	15	15
Female	5	6	6
Age (years)	37.9±12.8	37.4±13.7	35.23±11.4
ALT (IU/L)	73.1 (10–412)	82.8 (19–354)	22.3 (14–43)
AST (IU/L)	53.3 (25–207)	60.0 (21–225)	22.0 (16–49)
GGT (IU/L)	53.5 (11–180)	46.6 (16–285)	20.8 (12–33)
ALP (IU/L)	89.3 (51–185)	84.6 (44–156)	62.3 (42–96)
TBIL (𝜇M/L)	16.2 (7.6–38.5)	17.4 (7.6–27.2)	16.3 (6.9–27.1)
HBV DNA	6079004 (0–94800000)	6706693 (0–62270000)	0
HBV status (𝑛)
HBsAg+	32	21	0
HBsAg−	0	0	21

Ages are given as mean ± S.D.; values of alanine aminotransferase (ALT), aspartate aminotransferase (AST), Gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP), total bilirubin (TBIL) and HBV DNA were given as medians (range). LGDHS: liver-gallbladder dampness-heat syndrome; LKYDS: liver-kidney yin deficiency syndrome; Ctrl: healthy donor; HBsAg: hepatitis B surface antigen; HBV: hepatitis B virus.